Calcipotriene and Emtricitabine, rilpivirine, and tenofovir interaction
Calcipotriene and Emtricitabine, rilpivirine, and tenofovir: the Emtricitabine, rilpivirine, and tenofovir prescribing label mentions this combination without an instruction to avoid it or change the dose.
Mentioned, no instruction to avoid. Worth knowing; rarely a reason to change anything on its own.
What the FDA labels say
From the Emtricitabine, rilpivirine, and tenofovir (COMPLERA) label · effective 2025-07-16
Serum parathyroid hormone levels and 1,25 Vitamin D levels were also higher in subjects receiving TDF.
Although the effect of supplementation with calcium and Vitamin D was not studied, such supplementation may be beneficial for all patients.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.